Article
Cytosolic DNA sensor AIM2 promotes KRAS-driven lung cancer independent of inflammasomes.
Cancer science - 1 Jun 2024
Alanazi Mohammad, Weng Teresa, McLeod Louise, Gearing Linden J, Smith Julian A, Kumar Beena, Saad Mohamed I, Jenkins Brendan J
Abstract excerpt
Constitutively active KRAS mutations are among the major drivers of lung cancer, yet the identity of molecular co-operators of oncogenic KRAS in the lung remains ill-defined. The innate immune cytosolic DNA sensor and pattern recognition receptor (PRR) Absent-in-melanoma 2 (AIM2) is best known for its assembly of multiprotein inflammasome complexes and promoting an inflammatory response. Here, we define a role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
